GB9828578D0 - Regulation - Google Patents

Regulation

Info

Publication number
GB9828578D0
GB9828578D0 GBGB9828578.6A GB9828578A GB9828578D0 GB 9828578 D0 GB9828578 D0 GB 9828578D0 GB 9828578 A GB9828578 A GB 9828578A GB 9828578 D0 GB9828578 D0 GB 9828578D0
Authority
GB
United Kingdom
Prior art keywords
regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9828578.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9828578.6A priority Critical patent/GB9828578D0/en
Publication of GB9828578D0 publication Critical patent/GB9828578D0/en
Priority to SI9930418T priority patent/SI1083934T1/en
Priority to PL99345207A priority patent/PL345207A1/en
Priority to TR2001/00348T priority patent/TR200100348T2/en
Priority to EP99925174A priority patent/EP1083934B1/en
Priority to CA002334171A priority patent/CA2334171A1/en
Priority to IDW20002711A priority patent/ID27483A/en
Priority to APAP/P/2000/001999A priority patent/AP2000001999A0/en
Priority to JP2000551815A priority patent/JP2002516676A/en
Priority to HU0103252A priority patent/HUP0103252A3/en
Priority to YU75600A priority patent/YU75600A/en
Priority to EA200001124A priority patent/EA200001124A1/en
Priority to DE69910202T priority patent/DE69910202T2/en
Priority to KR1020007013584A priority patent/KR20010043968A/en
Priority to EP02020179A priority patent/EP1281763A3/en
Priority to CN99809287A priority patent/CN1311822A/en
Priority to DK99925174T priority patent/DK1083934T3/en
Priority to PCT/GB1999/001722 priority patent/WO1999062561A2/en
Priority to ES99925174T priority patent/ES2205830T3/en
Priority to IL13993699A priority patent/IL139936A0/en
Priority to SK1832-2000A priority patent/SK18322000A3/en
Priority to US09/701,749 priority patent/US6689758B1/en
Priority to AT99925174T priority patent/ATE246518T1/en
Priority to NZ508505A priority patent/NZ508505A/en
Priority to AU41560/99A priority patent/AU770497B2/en
Priority to BR9910877-1A priority patent/BR9910877A/en
Priority to EEP200000790A priority patent/EE200000790A/en
Priority to TR2001/02985T priority patent/TR200102985T2/en
Priority to PT99925174T priority patent/PT1083934E/en
Priority to IS5742A priority patent/IS5742A/en
Priority to NO20006047A priority patent/NO20006047L/en
Priority to HR20000832A priority patent/HRP20000832A2/en
Priority to HK01105197A priority patent/HK1034465A1/en
Ceased legal-status Critical Current

Links

GBGB9828578.6A 1998-06-02 1998-12-23 Regulation Ceased GB9828578D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GBGB9828578.6A GB9828578D0 (en) 1998-12-23 1998-12-23 Regulation
PT99925174T PT1083934E (en) 1998-06-02 1999-06-02 EGR-1 FOR THE PRODUCTION OF A WOUND TREATMENT MEDICINE
DK99925174T DK1083934T3 (en) 1998-06-02 1999-06-02 gene Therapy Methods
ES99925174T ES2205830T3 (en) 1998-06-02 1999-06-02 EGR-1 FOR THE PREPARATION OF A MEDICINAL PRODUCT TO TREAT WOUNDS.
TR2001/00348T TR200100348T2 (en) 1998-06-02 1999-06-02 Gene therapy techniques
PCT/GB1999/001722 WO1999062561A2 (en) 1998-06-02 1999-06-02 Gene therapy method
CA002334171A CA2334171A1 (en) 1998-06-02 1999-06-02 Gene therapy method
IDW20002711A ID27483A (en) 1998-06-02 1999-06-02 GENERAL THERAPY METHOD
APAP/P/2000/001999A AP2000001999A0 (en) 1998-06-02 1999-06-02 Gene therapy method.
PL99345207A PL345207A1 (en) 1998-06-02 1999-06-02 Gene therapy method
HU0103252A HUP0103252A3 (en) 1998-06-02 1999-06-02 Gene therapy method
YU75600A YU75600A (en) 1998-06-02 1999-06-02 Application of polypeptides of e
EA200001124A EA200001124A1 (en) 1998-06-02 1999-06-02 METHOD OF GENE THERAPY
DE69910202T DE69910202T2 (en) 1998-06-02 1999-06-02 EGR-1 for the manufacture of a medicament for the treatment of wounds
KR1020007013584A KR20010043968A (en) 1998-06-02 1999-06-02 Gene Therapy Method
IL13993699A IL139936A0 (en) 1998-06-02 1999-06-02 Gene therapy method
CN99809287A CN1311822A (en) 1998-06-02 1999-06-02 Gene therapy method
SI9930418T SI1083934T1 (en) 1998-06-02 1999-06-02 EGR-1 for the manufacture of a medicament for treating wounds
EP99925174A EP1083934B1 (en) 1998-06-02 1999-06-02 EGR-1 for the manufacture of a medicament for treating wounds
JP2000551815A JP2002516676A (en) 1998-06-02 1999-06-02 Gene therapy
EP02020179A EP1281763A3 (en) 1998-06-02 1999-06-02 Early growth response-1 (EGR-1) transcription factor
SK1832-2000A SK18322000A3 (en) 1998-06-02 1999-06-02 Use of nucleic acid molecule, pharmaceutical composition containing it and a nucleic acid molecule
US09/701,749 US6689758B1 (en) 1998-06-02 1999-06-02 Gene therapy method
AT99925174T ATE246518T1 (en) 1998-06-02 1999-06-02 EGR-1 FOR PRODUCING A MEDICATION FOR THE TREATMENT OF WOUNDS
NZ508505A NZ508505A (en) 1998-06-02 1999-06-02 Treatment of wounds using an Egr-1 transcription factor polypeptide
AU41560/99A AU770497B2 (en) 1998-06-02 1999-06-02 Gene therapy method
BR9910877-1A BR9910877A (en) 1998-06-02 1999-06-02 Use of a nucleic acid molecule and a polypeptide, nucleic acid molecule, pharmaceutical composition, polypeptide, nucleic acid vector, cell, wound treatment processes in a mammal and a patient, diagnosis, selection, identification of an agent capable of supra-regular or infra-regular transcription of egr-1, and, agent
EEP200000790A EE200000790A (en) 1998-06-02 1999-06-02 Gene therapy method
TR2001/02985T TR200102985T2 (en) 1998-06-02 1999-06-02 Gene therapy techniques.
IS5742A IS5742A (en) 1998-06-02 2000-11-28 Method of gene therapy
NO20006047A NO20006047L (en) 1998-06-02 2000-11-29 Procedures for gene therapy
HR20000832A HRP20000832A2 (en) 1998-06-02 2000-12-01 Gene therapy method
HK01105197A HK1034465A1 (en) 1998-06-02 2001-07-24 Egr-1 for the manufacturing of a medicament for treating wounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828578.6A GB9828578D0 (en) 1998-12-23 1998-12-23 Regulation

Publications (1)

Publication Number Publication Date
GB9828578D0 true GB9828578D0 (en) 1999-02-17

Family

ID=10844990

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9828578.6A Ceased GB9828578D0 (en) 1998-06-02 1998-12-23 Regulation

Country Status (1)

Country Link
GB (1) GB9828578D0 (en)

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE69924108D1 (en) Offshore-bohrsystem
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE69918845D1 (en) Polyketonlösung
DE69913545D1 (en) Pyrimidonderivate
DE69943409D1 (en) Fmcw-radar
EA199900308A3 (en) Swichgear
DE69904335D1 (en) Aminomethylcarbonsäurederivate
DE69914921D1 (en) Phenyl-xanthinderivate
DE69835235D1 (en) Thermoplastische silikonelastomere
DE69940558D1 (en) Fluoromonomerpolymerisation
DE59903023D1 (en) Perorale wirkstoff-suspension
DE59914151D1 (en) Arylalkanoylpyridazine
DE69934603D1 (en) Elektrophotographischer photoconduktor
DE69908871D1 (en) Thermisch härtbare glasplatte
DE69915628D1 (en) Ritonavir-polymorph
DE60042897D1 (en) Photovervielfacherröhre
DE69939823D1 (en) Endo-beta-n-acetylglukosaminidase
DE69938146D1 (en) Ptc-chip-thermistor
DE69904442D1 (en) Cyclohexandiol-derivate
DE69905001D1 (en) Koagulationsvorrichtung
DE69925859D1 (en) Cycloalkylsubstituierte aminomethylpyrrolidin-derivate
DE59904407D1 (en) Chromanderivate
EP1059091A4 (en) Transmucous sorbefacients
EP1083910A4 (en) nrdE

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)